A carregar...
Publicação
Health economic evaluations of Covid-19 vaccines: a systematic literature review
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 513.59 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
The outbreak of the COVID-19 pandemic provoked more than six million deaths worldwide
between 2019 and 2022 and posed a heavy burden on the healthcare systems. The initial non pharmaceutical interventions to mitigate the spread of the virus proved to be not sustainable in
the long run due to excessive productivity losses. Governments, academic and the private sector
invested to produce efficient and safe vaccines. Vaccines are evaluated primarily by their
clinical outcomes. However, Health Economic Evaluations of COVID-19 vaccines are also an
important tool for policy makers to determine the optimal vaccination strategy in their
countries. The existing economic literature about COVID-19 vaccines includes cost-benefit and
cost-effectiveness analysis, based on real world evidence (RWE) as well as modelling studies.
The objective of this Systematic Literature Review is to report the main evidence from the
economic evaluations of the vaccination programs against COVID-19 that have been made as
of summer 2022. Data on key economic outcomes were extracted from 16 scientific papers,
selected from an initial list of 1842 studies on the PubMed database. The criteria for inclusion
of the studies in this research considered specific restrictions for population, intervention,
outcomes, and study design characteristics. The results were then reported following the
Cochrane Handbook for Systematic Literature Review. The results indicate that Covid-19
vaccines and vaccination programs are cost-effective and have a positive impact on countries
from a social and economic perspective
Descrição
Palavras-chave
Health Covid-19 Health economic evaluation & outcome Research Systematic literature review Iqvia Vaccines